Title |
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy
|
---|---|
Published in |
Cancer Management and Research, December 2021
|
DOI | 10.2147/cmar.s330195 |
Pubmed ID | |
Authors |
Valentina Burgio, Massimo Iavarone, Giovanni Giuseppe Di Costanzo, Fabio Marra, Sara Lonardi, Emiliano Tamburini, Fabio Piscaglia, Gianluca Masi, Ciro Celsa, Francesco Giuseppe Foschi, Marianna Silletta, Daniela Caterina Amoruso, Margherita Rimini, Mariangela Bruccoleri, Raffaella Tortora, Claudia Campani, Caterina Soldà, Massimo Giuseppe Viola, Antonella Forgione, Fabio Conti, Francesca Salani, Silvia Catanese, Carmelo Marco Giacchetto, Claudia Fulgenzi, Carmine Coppola, Pietro Lampertico, Antonio Pellino, Gabriele Rancatore, Giuseppe Cabibbo, Francesca Ratti, Federica Pedica, Angelo Della Corte, Massimo Colombo, Francesco De Cobelli, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Italy | 3 | 33% |
India | 1 | 11% |
Portugal | 1 | 11% |
United States | 1 | 11% |
Unknown | 3 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 67% |
Scientists | 3 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 10 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 1 | 10% |
Librarian | 1 | 10% |
Student > Bachelor | 1 | 10% |
Student > Postgraduate | 1 | 10% |
Unknown | 6 | 60% |
Readers by discipline | Count | As % |
---|---|---|
Arts and Humanities | 1 | 10% |
Unspecified | 1 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 10% |
Medicine and Dentistry | 1 | 10% |
Unknown | 6 | 60% |